Research ArticleClinical Studies
Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
TAKESHI FUJISAWA, HIDEHIRO HOJO, MASAKI NAKAMURA, KENJI MAKITA, HIDENARI HIRATA, HIDEKAZU OYOSHI, KENTO TOMIZAWA, YUZHENG ZHOU, KEIKO FUKUSHI, MASAFUMI IKEDA and SADAMOTO ZENDA
Anticancer Research March 2025, 45 (3) 1159-1169; DOI: https://doi.org/10.21873/anticanres.17503
TAKESHI FUJISAWA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
HIDEHIRO HOJO
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
MASAKI NAKAMURA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
KENJI MAKITA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
2Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan;
HIDENARI HIRATA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
HIDEKAZU OYOSHI
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
KENTO TOMIZAWA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
YUZHENG ZHOU
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
KEIKO FUKUSHI
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
MASAFUMI IKEDA
3Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan
SADAMOTO ZENDA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
TAKESHI FUJISAWA, HIDEHIRO HOJO, MASAKI NAKAMURA, KENJI MAKITA, HIDENARI HIRATA, HIDEKAZU OYOSHI, KENTO TOMIZAWA, YUZHENG ZHOU, KEIKO FUKUSHI, MASAFUMI IKEDA, SADAMOTO ZENDA
Anticancer Research Mar 2025, 45 (3) 1159-1169; DOI: 10.21873/anticanres.17503
Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
TAKESHI FUJISAWA, HIDEHIRO HOJO, MASAKI NAKAMURA, KENJI MAKITA, HIDENARI HIRATA, HIDEKAZU OYOSHI, KENTO TOMIZAWA, YUZHENG ZHOU, KEIKO FUKUSHI, MASAFUMI IKEDA, SADAMOTO ZENDA
Anticancer Research Mar 2025, 45 (3) 1159-1169; DOI: 10.21873/anticanres.17503





